| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |